You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis

Citation Tools

Article menu

Download PDFPDF

Treatment
Original article
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lindström U, Glintborg B, Di Giuseppe D, et al
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis
RMD Open 2019;5:e001079. doi: 10.1136/rmdopen-2019-001079